Brain Mann | NPR
Dec. 13, 2022
Drug maker Emergent BioSolutions is seeking approval from the Food and Drug Administration to sell Narcan over the counter, without need for a prescription.
The medication, an easy-to-use nasal spray version of the drug naloxone, has a strong track record reversing deadly opioid overdoses, which have soared in recent years largely because of the spread of fentanyl.
By Joe Hernandez / NPR The overdose-reversing drug Narcan could soon be available to buy over the counter without a prescription, the Food and Drug Administration announced Wednesday. The FDA’s approval of the nasal spray Narcan — the brand name for the drug naloxone — means the medication could be more widely available across the U.S….
By Jan Hoffman | The New York Times Three teenage girls were found slumped in a car in the parking lot of a rural Tennessee high school last month, hours before graduation ceremonies. Two were dead from fentanyl overdoses. The third, a 17-year-old, was rushed to the hospital in critical condition. Two days later, she…
Alex Buben from Biobot Analytics discusses the wastewater-based monitoring program for high-risk substances.
By Sheraz Sadiq (OPB) In Oregon, people released from prison were 10 times more likely to overdose on opioids compared to the general population, according to a new study that tracked prison release and overdose data from 2014 to 2018. The risk of overdose doubled during the first two weeks of release, and formerly incarcerated women were…
Saving Lives From Overdose America’s overdose crisis impacts all of us. Families in small towns, large cities, Tribal lands, and every community in between are affected, no matter who they are, what they look like, or how much money they make. That’s why President Biden named beating the opioid and overdose crisis a key pillar…
Nov 2 (Reuters) – CVS Health Corp, Walgreens Boots Alliance Inc and Walmart Inc agreed to pay about $13.8 billion to resolve thousands of U.S. state and local lawsuits accusing the pharmacy chains of mishandling opioid pain drugs, potentially bringing years of litigation close to the finish line. CVS said on Wednesday it had agreed…